Liver cirrhosis and hepatic stellate cells

Acta Cirurgica Brasileira

Volumn 21, Issue SUPPL.1, 2006, Pages 54-57

  Brandão, Daniel Ferracioli ^a   Ramalho, Leandra Naira Zambelli ^a   Ramalho, Fernando Silva ^a   Zucoloto, Sérgio ^a   Martinelli, Ana De Lourdes Candolo ^a   De Castro E Silva, Orlando ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Division of Gastroenterology   (Brazil)

Author keywords

Hepatic Cirrhosis; Hepatic Fibrosis; Liver; Perisinusoidal Cells; Portal Hypertension; Stellate Cells

Indexed keywords

CITOCIN; CYTOKINE; GROWTH FACTOR; PROSTAGLANDIN; RETINOL; UNCLASSIFIED DRUG;

AUTOIMMUNE HEPATITIS; CELL MOTILITY; CELL PROLIFERATION; EXTRACELLULAR MATRIX; HUMAN; KUPFFER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; PHENOTYPE; REVIEW; STELLATE CELL;

EID: 33749626699     PISSN: 01028650     EISSN: 16782674     Source Type: Journal    
DOI: 10.1590/S0102-86502006000700013     Document Type: Review

References (30)

1. Almdal TP, Sorensen TIA. The Danish Association for the Study of the Liver: Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: Analysis of hospitalization registry data. Hepatology. 1991; 13: 650-5.
2. Hay JE, Czaja AJ, Rakela J, Ludwig J. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology. 1987; 7: 49-54.
3. Conn HO, Atterbury CE. Cirrhosis. In: SCHIFF, L. & SCHIFF, E.R. Diseases of the Liver. 6ed. Philadelphia, JB Lippincott; 1987. p 725-864.
4. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Sheuer PJ, Sobin LH. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol. 1978; 31: 395-414.
5. Yeong ML, Nicholson GI, Lee SP. Regression of biliary cirrhosis following choledochal cyst drainage. Gastroenterology. 1982; 82: 332-5.
6. Groszmann RJ, Atterbury CE. The pathophysiology of portal hypertension: a basis for classification. Semin Liver Dis. 1982; 2: 177-86.
7. Orrego H, Blake JE, Blendis LM, Medline A. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. Gastroenterology. 1987; 92: 208-14.
8. Barnett JL, Appelman HD, Moseley RH. A familial form of incomplete septal cirrhosis. Gastroenterology. 1992; 102: 674-8.
9. Takahashi T. Three-dimensional morphology of the liver in cirrhosis. Virchows Arch [A]. 1978; 377: 97-110.
10. Fausto N, Mead JE. Regulation of liver growth: Protooncogenes and transforming growth factors. Lab Invest. 1989; 60: 4-13.
11. Callea F, Brisigotti M, Fabbretti G, Sciot R, Van Eyken P, Favret M. Cirrhosis of the liver. A regenerative process. Dig Dis Sci. 1991; 36: 1287-93.
12. Marbet UA, Bianchi L, Meury U, Stalder GA. Long-term histological evaluation of the natural history and prognostic factors of alcoholic liver disease. J Hepatol. 1987; 4: 364-72.
13. Nyfors A, Poulsen H. Morphogenesis of fibrosis and cirrhosis in methotrexate-treated patients with psoriasis. Am J Surg Pathol. 1977; 1: 235-43.
14. Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and stastical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology. 1987; 7: 660-4.
15. Okuda K. Hepatocellular carcinoma: Recent progress. Hepatology. 1992; 15: 948-63.
16. Chojkier M, Brenner DA. Therapeutic stragegies for hepatic fibrosis. Hepatology. 1988; 8: 176-82.
17. Maddrey WC, Van Thiel DH. Liver transplantation: An overview. Hepatology. 1988; 8: 948-59.
18. Knook DL. Fat-storing cells of the rat liver. Their isolation and purification. Exp Cell Res. 1982; 139: 468-71.
19. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000; 275: 2247-50.
20. Kawada N. The hepatic perisinusoidal stellate cell. Histol Histopathol. 1997; 12: 1069-80.
21. Rippe RA. Life or death: the fate of the hepatic stellate cell following hepatic injury. Hepatology. 1998; 27: 1447-8.
22. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis. 2001; 21: 311-29.
23. Pinzani M, Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis. 2001; 21: 397-412.
24. Pinzani M, Marra F, Carloni V. Signal transduction in hepatic stellate cells. Liver. 1998; 18: 2-13.
25. Clouston AD, Jonsson JR, Purdie DM, Macdonald GA, Pandeya N, Shorthouse C, Powell EE. Steatosis and chronic hepatitis C: analysis of fibrosis and stellate cell activation. J Hepatol. 2001; 34: 314-20.
26. Martinelli ALC, Ramalho LNZ, Zucoloto S. Hepatic stellate cells in hepatitis C patients: relationship with liver iron deposits and severity of liver disease. J Gastroenterol Hepatol. 2004; 19: 91-8.
27. Yamaoka K, Nouchi T, Marumo F, Sato C. á-smooth-muscle actin expression in normal and fibrotic human livers. Dig Dis Sci. 1993; 38: 1473-9.
28. Guido M, Rugge M, Chemello L, Leandro G, Fattovich G, Giustina G, Cassaro M, Alberti A. Liver stellate cells in chronic viral hepatitis: the effect of interferon therapy. J Hepatol. 1996; 24: 301-7.
29. Chang D, Ramalho LN, Ramalho FS, Martinelli AL, Zucoloto S. Hepatic stellate cells in human schistosomiasis: a comparative immunohistochemical study with liver cirrhosis. Acta Trop. 2006; 97:318-23.
30. Cassiman D, Libbrecht L, Desmet V, Denef C, Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol. 2002; 36: 200-9.